This federal contract award, with a ceiling value of $1,394.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order (SPE2D021DA002|SPE2D325F1338) for the provision of Epinephrine Injection USP 1:1000 Automat, a specialized pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of November 12, 2024.
DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. This contract award is not associated with a specific set-aside designation, allowing the company to leverage its status as a woman-owned small business to secure direct federal awards across various product categories and medical domains.
Additionally, DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.
Generated 2/7/25, 9:02 AM